Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Seikagaku and Ono enter codevelopment and marketing collaboration on SI-613

May 15, 2017

FLX-787 demonstrates clinical benefit for treating nocturnal leg cramping

May 5, 2017

FDA accepts for review Xeljanz sNDAs for psoriatic arthritis

May 4, 2017

GlaxoSmithKline divulges BRD4 inhibitors

May 2, 2017

Trial finds urolithin A safe in healthy elderly subjects

May 2, 2017

Kyowa Hakko Kirin initiates global phase III trial of brodalumab in axial spondyloarthritis

April 26, 2017

EMA committee recommends E.U. approval of Kevzara

April 24, 2017

AbbVie conducting second phase III study of ABT-494 in psoriatic arthritis

April 24, 2017

FDA approves infliximab biosimilar Renflexis

April 24, 2017

AbbVie initiates phase III study of ABT-494 for psoriatic arthritis

April 20, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.